TIGENIX, created in 2000 (Belgium), from 440 sister brands and 4958 competing brands. TIGENIX is owned by Takeda Pharmaceutical, listed on the stock exchange of Francfort Its International Securities Identification Number (ISIN) is JP3463000004. The sector of TIGENIX is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(TIGENIX)
over 5 years*
EUR 18.63